Schlösser R - Search Results

1

Prolactin plasma levels and D2-dopamine receptor occupancy measured with IBZM-SPECT.

Schlegel S, Schlösser R, Hiemke C, Nickel O, Bockisch A, Hahn K. Schlegel S, et al. Among authors: schlosser r. Psychopharmacology (Berl). 1996 Apr;124(3):285-7. doi: 10.1007/BF02246671. Psychopharmacology (Berl). 1996. PMID: 8740053

2

D2-receptor imaging with [123I]IBZM and single photon emission tomography in psychiatry: a survey of current status.

Schlösser R, Schlegel S. Schlösser R, et al. J Neural Transm Gen Sect. 1995;99(1-3):173-85. doi: 10.1007/BF01271477. J Neural Transm Gen Sect. 1995. PMID: 8579803 Review.

3

[123I]IBZM SPECT in patients treated with typical and atypical neuroleptics: relationship to drug plasma levels and extrapyramidal side effects.

Schlösser R, Schlegel S, Hiemke C, Nickel O, Bockisch A, Rao ML, Hahn K. Schlösser R, et al. Psychiatry Res. 1997 Sep 29;75(2):103-14. doi: 10.1016/s0925-4927(97)00044-9. Psychiatry Res. 1997. PMID: 9351492

4

Occupancy of striatal D(2)-like dopamine receptors after treatment with the sigma ligand EMD 57445, a putative atypical antipsychotic.

Gründer G, Müller MJ, Andreas J, Heydari N, Wetzel H, Schlösser R, Schlegel S, Nickel O, Eissner D, Benkert O. Gründer G, et al. Among authors: schlosser r. Psychopharmacology (Berl). 1999 Sep 1;146(1):81-6. doi: 10.1007/s002130051091. Psychopharmacology (Berl). 1999. PMID: 10485968

5

Neuroendocrine response to antipsychotics: effects of drug type and gender.

Gründer G, Wetzel H, Schlösser R, Anghelescu I, Hillert A, Lange K, Hiemke C, Benkert O. Gründer G, et al. Among authors: schlosser r. Biol Psychiatry. 1999 Jan 1;45(1):89-97. doi: 10.1016/s0006-3223(98)00125-5. Biol Psychiatry. 1999. PMID: 9894580 Clinical Trial.

6

Long-term effects of the substituted benzamide derivative amisulpride on baseline and stimulated prolactin levels.

Schlösser R, Gründer G, Anghelescu I, Hillert A, Ewald-Gründer S, Hiemke C, Benkert O. Schlösser R, et al. Neuropsychobiology. 2002;46(1):33-40. doi: 10.1159/000063574. Neuropsychobiology. 2002. PMID: 12207145 Clinical Trial.

7

Effects of subchronic paroxetine administration on night-time endocrinological profiles in healthy male volunteers.

Schlösser R, Wetzel H, Dörr H, Rossbach W, Hiemke C, Benkert O. Schlösser R, et al. Psychoneuroendocrinology. 2000 May;25(4):377-88. doi: 10.1016/s0306-4530(99)00065-7. Psychoneuroendocrinology. 2000. PMID: 10725614 Clinical Trial.

8

Akathisia and suicidal ideation in first-episode schizophrenia.

Seemüller F, Schennach R, Mayr A, Musil R, Jäger M, Maier W, Klingenberg S, Heuser I, Klosterkötter J, Gastpar M, Schmitt A, Schlösser R, Schneider F, Ohmann C, Lewitzka U, Gaebel W, Möller HJ, Riedel M; German Study Group on First-Episode Schizophrenia. Seemüller F, et al. Among authors: schlosser r. J Clin Psychopharmacol. 2012 Oct;32(5):694-8. doi: 10.1097/JCP.0b013e3182677958. J Clin Psychopharmacol. 2012. PMID: 22926606 Clinical Trial.

9

Analysis of sleep EEG microstructure in subchronic paroxetine treatment of healthy subjects.

Röschke J, Kögel P, Schlösser R, Wagner P, Mann K, Rossbach W, Benkert O. Röschke J, et al. Among authors: schlosser r. Psychopharmacology (Berl). 1997 Jul;132(1):44-9. doi: 10.1007/s002130050318. Psychopharmacology (Berl). 1997. PMID: 9272758 Clinical Trial.

10

[Detection of neurotransmitter interactions with PET and SPECT by pharmacological challenge paradigms].

Schlösser R. Schlösser R. Nervenarzt. 2000 Jan;71(1):9-18. doi: 10.1007/s001150050002. Nervenarzt. 2000. PMID: 10695027 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

683 results

Search Page

Filters